PXN and chronic myelogenous leukemia, BCR-ABL1 positive: By employing RT-PCR analysis, it was observed that the level of PXN-AS1 was significantly higher in samples from CML patients who were resistant to Imatinib compared to those who were sensitive to Imatinib.